- CA$2.80bn
- CA$2.64bn
- CA$1.18bn
- 75
- 49
- 90
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 782 | 504 | 834 | 1,225 | 1,177 |
Cost of Revenue | |||||
Gross Profit | 514 | 318 | 518 | 729 | 686 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 792 | 1,128 | 472 | 1,001 | 1,007 |
Operating Profit | -9.48 | -624 | 362 | 224 | 171 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 247 | -658 | 458 | 159 | -37.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 247 | -658 | 458 | 572 | -51.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 247 | -658 | 458 | 572 | -51.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 247 | -658 | 458 | 572 | -51.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.046 | -0.381 | 0.168 | 0.886 | 0.112 |